The recall has been issued for some products due to higher than acceptable levels of benzene, a chemical linked to leukemia ...

It marks the end of an 11-year dispute that started when two whistleblowers claimed Walgreens’ practices violated the False ...

We came across a bearish thesis on Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on ValueInvestorsClub by quads1025. In this ...

The mixed messaging diluted Walgreens’ identity. Was it a healthcare leader ... than systematic Great marketing doesn’t just sell products, it reinforces a brand’s purpose and creates ...

Walgreens’ market value had shrunk to ... which are ongoing. Selling consumer health care products from stores is a low-growth business facing competition from Amazon.com Inc. and WalMart ...

More than a half dozen acne products that may be contaminated with ... adverse reactions to a recalled product. Patients and health care professionals are urged by the FDA to complete and submit ...

Walgreens’ market value had shrunk to ... The pharmacist has endured myriad problems, which are ongoing. Selling consumer healthcare products from stores is a low-growth business facing ...

The US healthcare business expands Walgreens ... but we think growth in Walgreens-branded products and general merchandise sales as well as managing shrink levels will offset store closures.

Last September, Walgreens Boots Alliance agreed to pay a combined $106.8 million to the federal government and states for submitting claims to federal healthcare ... types of products and services ...